Skip to main content
TipRanks
Go Ultimate75% OFF

Ildong Pharmaceutical Co., Ltd. (249420) Income Statement

Ildong Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2026), Ildong Pharmaceutical Co., Ltd.'s total revenue was ₩147.86B, an increase of 6.77% from the same quarter last year. In Q2, Ildong Pharmaceutical Co., Ltd.'s net income was ₩5.70B. See Ildong Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
₩ 566.93B₩ 614.94B₩ 600.76B₩ 637.71B₩ 560.13B
₩ 214.76B₩ 233.46B₩ 207.54B₩ 236.34B₩ 219.44B
₩ 197.44B₩ 220.34B₩ 260.96B₩ 309.68B₩ 273.82B
Depreciation and Amortization₩ 22.58B₩ 25.94B₩ 28.32B₩ 29.54B₩ 29.31B
₩ 39.90B₩ 33.59B₩ -51.23B₩ -80.49B₩ -101.34B
₩ 17.32B₩ 13.12B₩ -53.42B₩ -73.33B₩ -54.38B
₩ 12.25B₩ -23.81B₩ -40.86B₩ -46.34B₩ -86.83B
₩ 31.80B₩ -10.69B₩ -94.27B₩ -119.82B₩ -141.21B
₩ 27.66B₩ -4.58B₩ -78.93B₩ -142.17B₩ -99.71B
Per Share Metrics
Basic EPS₩ 942.08₩ -163.63₩ -2920.01₩ -5396.73₩ -4191.88
Diluted EPS₩ 936.77₩ -163.63₩ -2920.01₩ -5396.73₩ -4191.88
Weighted Average Shares Outstanding30.04M27.93M27.03M26.34M23.79M
Weighted Average Shares Outstanding (Diluted)30.04M27.93M27.03M26.34M23.79M

Currency in KRW

Ildong Pharmaceutical Co., Ltd. Earnings and Revenue History

-400B0400B800B-24 %-12 %0 %12 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin